Gleb Slobodin
- Rheumatology top 1%
- Epidemiology top 5%
- Immunology top 5%
- Hepatology top 2%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Itzhak RosnerMichael RozenbaumNina BoulmanJochanan E. NaschitzElias ToubiAharon KesselDaniel YeshurunDoron Rimar
- Topics
- Spondyloarthritis Studies and Treatments (29 papers)Systemic Sclerosis and Related Diseases (20 papers)Rheumatoid Arthritis Research and Therapies (19 papers)
- Cited by
- HepatologyRheumatologyImmunology
- Journals
- SHILAP Revista de lepidopterologíaJournal of VirologyInternational Journal of Molecular Sciences
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Gleb Slobodin
133 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 105
- Rheumatology 752
- Epidemiology 543
- Immunology 495
- Hepatology 414
- Pathology and Forensic Medicine 383
Countries citing papers authored by Gleb Slobodin
This map shows the geographic impact of Gleb Slobodin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gleb Slobodin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gleb Slobodin more than expected).
Fields of papers citing papers by Gleb Slobodin
This network shows the impact of papers produced by Gleb Slobodin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gleb Slobodin. The network helps show where Gleb Slobodin may publish in the future.
Co-authorship network of co-authors of Gleb Slobodin
This figure shows the co-authorship network connecting the top 25 collaborators of Gleb Slobodin. A scholar is included among the top collaborators of Gleb Slobodin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gleb Slobodin. Gleb Slobodin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 6 | |
| 7 | A high and equal prevalence of the Q703K variant in NLRP3 patients with autoinflammatory symptoms and ethnically matched controls. | 5 |
| 8 | 9 | |
| 9 | 21 | |
| 10 | 0 | |
| 11 | 8 | |
| 12 | Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy. | 41 |
| 13 | 74 | |
| 14 | Isolated periaortitis: Clinical and imaging characteristics | 6 |
| 15 | 59 | |
| 16 | 4 | |
| 17 | Quantitation of liver and spleen uptake of (99m)Tc-phytate colloid using SPECT: detection of liver cirrhosis. | 23 |
| 18 | 2 | |
| 19 | 197 | |
| 20 | 66 |
About Gleb Slobodin
Gleb Slobodin is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine, having authored 141 papers that have together received 2.3k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (29 papers), Systemic Sclerosis and Related Diseases (20 papers) and Rheumatoid Arthritis Research and Therapies (19 papers). The work is most often cited by research in Hepatology (414 citations), Rheumatology (752 citations) and Immunology (495 citations). Gleb Slobodin has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Itzhak Rosner, Michael Rozenbaum, Nina Boulman, Jochanan E. Naschitz, Elias Toubi, Aharon Kessel, Daniel Yeshurun, Doron Rimar, Eli Zuckerman and E. Zuckerman. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Virology and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.